RIGEL PHARMACEUTICALS INC Quarterly Return On Assets in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from Q4 2021 to Q3 2024.
  • Rigel Pharmaceuticals Inc Return On Assets for the quarter ending September 30, 2024 was 3.03 %.
  • Rigel Pharmaceuticals Inc annual Return On Assets for 2023 was -21.2 %, a 52.3% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Return On Assets for 2022 was -44.5 %, a 379% decline from 2021.
  • Rigel Pharmaceuticals Inc annual Return On Assets for 2021 was -9.29 %, a 59.8% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 3.03 +23 Jul 1, 2024 Sep 30, 2024
Q2 2024 -11.7 +19.1 +62.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -16.6 +19 +53.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -21.2 +23.3 +52.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -19.9 +39.1 +66.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -30.8 +22.8 +42.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -35.6 +12.6 +26.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -44.5 -35.2 -379% Oct 1, 2022 Dec 31, 2022
Q3 2022 -59 Jul 1, 2022 Sep 30, 2022
Q2 2022 -53.6 Apr 1, 2022 Jun 30, 2022
Q1 2022 -48.2 Jan 1, 2022 Mar 31, 2022
Q4 2021 -9.29 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.